VREXVarex Imaging Corporation
$10.29+29% 1Y
$10.29
$9.3252 weeks$18.58
Is the price fair?
Mixed
1 neutral, 2 without dataIn its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Vs its own P/E rangemid-range for this companyderived
In its normal range: P/E 34.8 vs a 29.7 median over 26 quarters (+17% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What VREX's price assumes
Varex Imaging Corporation trades at 34.8× earnings against 25.8× for the median Medical Devices name, more expensive than its own group.
34.8
Trailing P/E · Medical Devices median 25.8 · 1.35× the median: the market pays up for this one
Details›
- Healthcare median P/E509 names
- 26.0
- Medical Devices median P/E64 names
- 25.8
- Market capitalisation
- $778M
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $11.91 |
| Its own P/E history, median | $15.73 |
| Its own P/E history, upper quartile | $26.82 |
| 52-week range | $9.32 – $18.57 |
| Today | $10.29 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.